The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials

Jasper Brugts; M Bertrand; W Remme; R Ferrari; K Fox; S MacMahon; J Chalmers; Maarten Simoons; Eric Boersma

doi:10.1007/s10557-017-6747-9

The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials

Jasper Brugts, M Bertrand, W Remme, R Ferrari, K Fox, S MacMahon, J Chalmers, Maarten Simoons, Eric Boersma

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

5 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	391-400
Number of pages	10
Journal	Cardiovascular Drugs & Therapy
Volume	31
Issue number	4
DOIs	https://doi.org/10.1007/s10557-017-6747-9
Publication status	Published - 2017

Access to Document

10.1007/s10557-017-6747-9

REPUB_101737.pdfFinal published version, 676 KB

http://hdl.handle.net/1765/101737

Cite this

Brugts, J., Bertrand, M., Remme, W., Ferrari, R., Fox, K., MacMahon, S., Chalmers, J., Simoons, M., & Boersma, E. (2017). The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials. Cardiovascular Drugs & Therapy, 31(4), 391-400. https://doi.org/10.1007/s10557-017-6747-9

@article{c20577ec621a4897a4f7573ea54d9b18,

title = "The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials",

author = "Jasper Brugts and M Bertrand and W Remme and R Ferrari and K Fox and S MacMahon and J Chalmers and Maarten Simoons and Eric Boersma",

year = "2017",

doi = "10.1007/s10557-017-6747-9",

language = "Undefined/Unknown",

volume = "31",

pages = "391--400",

journal = "Cardiovascular Drugs & Therapy",

issn = "0920-3206",

number = "4",

}

Brugts, J, Bertrand, M, Remme, W, Ferrari, R, Fox, K, MacMahon, S, Chalmers, J, Simoons, M & Boersma, E 2017, 'The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials', Cardiovascular Drugs & Therapy, vol. 31, no. 4, pp. 391-400. https://doi.org/10.1007/s10557-017-6747-9

The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials. / Brugts, Jasper; Bertrand, M; Remme, W et al.
In: Cardiovascular Drugs & Therapy, Vol. 31, No. 4, 2017, p. 391-400.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials

AU - Brugts, Jasper

AU - Bertrand, M

AU - Remme, W

AU - Ferrari, R

AU - Fox, K

AU - MacMahon, S

AU - Chalmers, J

AU - Simoons, Maarten

AU - Boersma, Eric

PY - 2017

Y1 - 2017

U2 - 10.1007/s10557-017-6747-9

DO - 10.1007/s10557-017-6747-9

M3 - Article

SN - 0920-3206

VL - 31

SP - 391

EP - 400

JO - Cardiovascular Drugs & Therapy

JF - Cardiovascular Drugs & Therapy

IS - 4

ER -

Brugts J, Bertrand M, Remme W, Ferrari R, Fox K, MacMahon S et al. The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials. Cardiovascular Drugs & Therapy. 2017;31(4):391-400. doi: 10.1007/s10557-017-6747-9